Jazz Pharmaceuticals plc (JAZZ) : During the past 4 weeks, traders have been relatively bearish on Jazz Pharmaceuticals plc (JAZZ), hence the stock is down -5.07% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -9.39% relative to the S&P 500. The 4-week change in the price of the stock is -4.09% and the stock has fallen -9.34% in the past 1 week.
The stock has recorded a 20-day Moving Average of 6.12% and the 50-Day Moving Average is 5.86%. Jazz Pharmaceuticals plc (NASDAQ:JAZZ): On Fridays trading session , Opening price of the stock was $138.08 with an intraday high of $138.542. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $136.02. However, the stock managed to close at $136.56, a loss of 1.10% for the day. On the previous day, the stock had closed at $138.08. The total traded volume of the day was 645,975 shares.
The company Insiders own 3.9% of Jazz Pharmaceuticals plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -2.17% . Institutional Investors own 90.4% of Jazz Pharmaceuticals plc shares. During last six month period, the net percent change held by insiders has seen a change of -4.09%. Also, Brokerage firm Deutsche Bank maintains its rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ). As per the latest information, the brokerage house raises the price target to $158 per share from a prior target of $155. The shares have been rated Buy. The rating by the firm was issued on August 11, 2016.